Chardan Capital Initiates Coverage On Adagene with Buy Rating, Announces Price Target of $9

Benzinga · 3d ago
Chardan Capital analyst Gautam Chukka initiates coverage on Adagene (NASDAQ:ADAG) with a Buy rating and announces Price Target of $9.